筹划购买某一国内药品技术等资产组，南新制药盘中“20cm”涨停

Group 1 - Nanjing Pharmaceutical (688189) experienced a significant stock price increase, reaching 17.14 CNY per share with a rise of 20.03% [1] - The company announced plans to acquire a domestic pharmaceutical technology asset group, although it is uncertain if this will constitute a major asset restructuring [1] - The acquisition is still in the planning stage, and no formal agreements have been signed, indicating substantial uncertainty regarding its successful implementation [1]